Preclinical Data on Aptose Biosciences FLT3/BTK Inhibitor CG’806 Presented at AACR Hematologic Malignancies Meeting May 08, 2017 8:00am EDT
OHSU and Aptose Present CG’806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies Meeting May 08, 2017 8:00am EDT
Aptose Biosciences to Participate at the Bloom Burton & Co. Healthcare Investor Conference 2017 Apr 25, 2017 8:30am EDT
Aptose To Release First Quarter Ended March 31, 2017 Financial Results and Hold Conference Call on May 11, 2017 Apr 24, 2017 8:30am EDT
Aptose Biosciences to Present CG’806 Data at AACR Hematologic Malignancies Meeting Apr 19, 2017 8:30am EDT
Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day Feb 02, 2017 7:00am EST
